|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| General and administrative expenses paid by related party included in note payable | ||
| Change in fair value of warrant liabilities | ||
| Offering costs associated with warrants issuance | ||
| Share based compensation | ||
| Net gain from Investments held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accounts payable | ||
| Accrued expenses | ||
| Accrued expenses - related party | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities | ||
| Cash deposited in Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds received from initial public offering, gross | ||
| Proceeds from private placement | ||
| Offering costs paid | ||
| Repayment of note payable from related party | ||
| Net cash provided by financing activities | ||
| Net change in cash | ||
| Cash - beginning of the period | ||
| Cash - end of the period | ||
| Cash - beginning of the period | ||
| Cash - end of the period | ||
| Supplemental disclosure of noncash investing and financing activities: | ||
| Offering costs included in accrued expenses | ||
| Offering costs included in note payable | ||
| Deferred underwriting commissions in connection with the initial public offering | ||
| Initial value of ordinary shares subject to possible redemption | ||
| Change in value of ordinary shares subject to possible redemption |
Loading...
